Assembly Biosciences, Inc. (ASMB) Assembly Biosciences' HBV Portfolio Progress Conference Call (Transcript)

Assembly Biosciences, Inc. (NASDAQ:ASMB) Assembly Biosciences’ HBV Portfolio Progress Conference Call May 7, 2020 4:30 PM ET Company Participants Amy Figueroa - Interim Investor Relations Consultant Dr. John McHutchison - CEO and President Dr. Luisa Stamm - CMO Tom Russo - CFO Richard Colonno - EVP and CSO Virology Operations Conference Call Participants Brian Skorney - Baird Brad Canino - SVB Leerink Michael Yee - Jefferies Salim Syed - Mizuho Raju Prasad - William Blair Operator Good afternoon and welcome ...